CED Clinic
  • What to Expect
    • Your First Visit
    • Patient Intake Form
  • Services Offered
    • Telemedicine
    • Pediatric Patients
    • Additional Services
  • Registration Resources
    • Registration Help
    • Next Steps
    • Caregiver Information
    • Cannabis Control Commission
  • Contact
    • Contact the Clinic
    • Social Media Links
    • Review Us!
    • Meet The Team >
      • Meet Dr. Caplan
      • Meet Dr. Exelbert
  • CED Clinic Events
    • Upcoming Events
    • Fireside Chats
    • Dispensary Highlights
    • Past Events
  • Information and FAQ
    • CED Clinic Cannabis Care
    • Cannabis FAQ
    • Recommended Online Resources
    • Patient Stories
    • CED Library
    • Printable Handouts >
      • Cannabis Journal
      • General Cannabis Info
      • Handouts for Illnesses >
        • Infectious Diseases
        • Mental Health
        • Skin Conditions
        • Neurological Disorders
        • Muscular and Skeletal Pain
        • Illnesses of Aging
        • Reproductive Health
        • Gastrointestinal Health
    • Awesome Extras! >
      • Vaporizing Overview
      • Unique Cannabinoids
      • MA Dispensary Map
      • Cannabis for Sleep
      • Topical Cannabis Products
      • Cooking with Cannabis
      • Cannabis Cookbook
  • Video Library
  • Massachusetts Dispensaries
  • Site Map
  • CED Blog
  • Blog
  • Socials
  • CED Clinic Services

CED Blog

Use the search bar above to explore our blog articles! 

A Cannabinoid-Like Compound Modulates Neuronal Excitability, May Reduce Seizures

3/26/2020

0 Comments

 
The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca2 -Activated K  Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing
In Summary
​Researchers have recently found a cannabinoid-like compound, VSN16R, which is able to modulate Ca2+- activated potassium channels and may reduce seizure severity. By hyperpolarizing the neurons through the opening of Ca2+- activated potassium channels VSN16R ultimately results in the reduction of hyperexcitability seen in individuals who suffer from seizures. The compiled data reveals that cannabinoids or compounds structurally similar to cannabinoids may prove useful in the treatment of seizures or epileptic disorders, similar to the cannabinol-based Epidiolex® medication for rare forms of epilepsy, reducing the chance of a seizure or minimizing its duration. Further research is needed to aid the development of more readily available cannabis-based therapies for seizure activity and more general forms of epilepsy. 
​
Highlighting in this article are the options for treatment that the endocannabinoid system provides us, even in the absence of naturally occurring cannabinoids. If structurally similar compounds like VSN16R are able to be synthesized and proven effective, it could mean novel therapies could be developed even while red tape surrounds cannabis. The endocannabinoid system affects a myriad of systems within the human body and is severely under-researched considering its potential. Epidiolex® is the only cannabinoid-based medication currently approved by the federal government but cannabis has shown promise in so many other areas where the current treatment is either ineffective or lacking. Research utilizing the endocannabinoid system as a target should continue and be pushed to the forefront of the medical community. 
The study is available for review or download here:
Download & Review HERE
View more studies like this in the CED Foundation Archive:  http://bit.ly/drcaplan 
0 Comments



Leave a Reply.

    Archives

    December 2021
    November 2021
    October 2021
    September 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    July 2019

    Categories

    All
    Adolescent
    Alcohol
    Analgesic
    Antitumor
    Anxiety
    Arthritis
    Athletes
    Australia
    Benzodiazepines
    Bioflavonoids
    Brain
    Breast Cancer
    Canada
    Cancer
    Cannabidiol
    Cannabinoid
    Cannabinoid Receptor 1
    Cannabinoid Receptor 2
    Cannabinoids
    Cannabis
    Cardiovascular
    CB1
    CB2
    CBD
    CBG
    CBN
    CBT
    Cessation
    Cholesterol
    Chronic Pain
    Clinical
    Cognitive
    Cognitive Health
    Colorado
    Consumption
    Coronavirus
    COVID 19
    COVID-19
    Curcumin
    Cytokine-induced Killer Cells
    Decarboxylation
    Dependence
    Diet
    Dispensaries
    Drug Abuse
    ECS
    Edibles
    Endocannabinoid System
    Entourage Effect
    Epilepsy
    Fasciae
    Fatty Acid
    FDA
    Feline
    Female Reproductive System
    Females
    Fibromyalgia
    Flavonoids
    Football
    Gastroenterology
    Growing
    Heart Disease
    Hemp
    History
    Hospitalization
    Hypothermia
    Illicit
    Industry
    Inflammation
    Injury
    Insomnia
    Israel
    Law
    Legalization
    Lung Cancer
    Male
    Marketing
    Massachusetts
    #MDTake
    Medical Cannabis
    Memory
    Men's Health
    Mental Health
    Metabolomics
    Mice
    Microdosing
    Military
    Multiple Myeloma
    Multiple Sclerosis
    Musculoskeletal
    Myofascial Tissue
    Neurodegenerative Conditions
    Neurological
    Neuroprotective Effect
    Neuropsychiatric Disorders
    NFL
    Nicotine
    Non-Cannabis Plant
    Norway
    Obesity
    Olfactory Ciruit
    Opioids
    Pain Relief
    Parkinson's Disease
    Pediatrics
    Pelvic Pain
    Pets
    Physical Activity
    Plant
    Pregnancy
    Prenatal
    Psoriasis
    Psychiatric
    Psychosis
    PTSD
    Public Health
    Recreational Cannabis
    Relaxing
    Respiratory
    Rheumatic Diseases
    Saliva
    Schizophrenia
    Seizures
    Seniors
    Sexual Intercourse
    Skin
    Smell
    Smoking
    Social Supports
    Spain
    Spinal Cord
    Sports
    Substance Abuse
    Suicide
    Synthetic
    Teratological
    Terpenes
    Tetrahydrocannabinol
    THC
    Therapy
    Tobacco
    Trauma
    UV Irradiation
    Vaping
    Veterans
    Women's Health
    Young Adults

    RSS Feed

Home

Need Registration Help?

Services Offered

Dispensaries

Contact the Clinic

Request Appointment
Copyright © 2022
  • What to Expect
    • Your First Visit
    • Patient Intake Form
  • Services Offered
    • Telemedicine
    • Pediatric Patients
    • Additional Services
  • Registration Resources
    • Registration Help
    • Next Steps
    • Caregiver Information
    • Cannabis Control Commission
  • Contact
    • Contact the Clinic
    • Social Media Links
    • Review Us!
    • Meet The Team >
      • Meet Dr. Caplan
      • Meet Dr. Exelbert
  • CED Clinic Events
    • Upcoming Events
    • Fireside Chats
    • Dispensary Highlights
    • Past Events
  • Information and FAQ
    • CED Clinic Cannabis Care
    • Cannabis FAQ
    • Recommended Online Resources
    • Patient Stories
    • CED Library
    • Printable Handouts >
      • Cannabis Journal
      • General Cannabis Info
      • Handouts for Illnesses >
        • Infectious Diseases
        • Mental Health
        • Skin Conditions
        • Neurological Disorders
        • Muscular and Skeletal Pain
        • Illnesses of Aging
        • Reproductive Health
        • Gastrointestinal Health
    • Awesome Extras! >
      • Vaporizing Overview
      • Unique Cannabinoids
      • MA Dispensary Map
      • Cannabis for Sleep
      • Topical Cannabis Products
      • Cooking with Cannabis
      • Cannabis Cookbook
  • Video Library
  • Massachusetts Dispensaries
  • Site Map
  • CED Blog
  • Blog
  • Socials
  • CED Clinic Services